Therapeutic education in atopic dermatitis:
A position paper from the International Eczema Council, (OPENED) task force.
Lawrence F.Eichenfield, Ayan Kusari, Allison M. Han, Sébastien Barbarot, Mette Deleuran, Peter Lio, Danielle Marcoux, Audrey Nosbaum, Jean-Francois Stalder
Volume 3, June 2021, Pages 8-13 ➜ PDF
Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional study, (OPENED) task force.
John C. Su, Nikolay Murashkin, Andreas Wollenberg, Åke Svensson, Pavel Chernyshov, Peter Lio, Dedee Murell, Audrey Nosbaum, Sébastien Faure, Sophie Mery, Jean-François Stalder
Research letter at JAAD International
Volume 4, September 2021, Pages 13-14 ➜ PDF
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force
L. Misery, A. Belloni Fortina, M. El Hachem, P. Chernyshov, L. von Kobyletzki, A. Heratizadeh, D. Marcoux, V. Aoki, M.C. Zaniboni, J.-F. Stalder, L.F. Eichenfield
J Eur Acad Dermatol Venereol. DOI: 10.1111/jdv.16916
Schmid-Grendelmeier R, Takaoka R, Ahogo KC, et al.
J Eur Acad Dermatol Venereol. 2019;33(11):2019-2028. doi:10.1111/jdv.15972
International Eczema Council (IEC)
See also the list of publications the International Eczema Council (IEC), an international organization that brings together dermatologists who are leaders in atopic dermatitis, and publishes on a regular basis expert consensus statements and research reviews.
European Task Force on Atopic Dermatitis (ETFAD)
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts.
J Eur Acad Dermatol Venereol, 2021 Mar 22. doi: 10.1111/jdv.17237. Online ahead of print
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics.
J Eur Acad Dermatol Venereol, First published: 15 February 2021